Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
复制标题
腰围比与心脏代谢性状,2型糖尿病和冠状动脉疾病的遗传关联。
DOI:
10.1001/jama.2016.21042
复制
发表时间:
2017-02-14
期刊:
影响因子:
--
通讯作者:
Kathiresan S
中科院分区:
文献类型:
--
作者:
Emdin CA;Khera AV;Natarajan P;Klarin D;Zekavat SM;Hsiao AJ;Kathiresan S
In observational studies, abdominal adiposity has been associated with type 2 diabetes and coronary heart disease (CHD). Whether these associations represent causal relationships remains uncertain. To test the association of a polygenic risk score for waist-to-hip ratio adjusted for body mass index (WHRadjBMI), a measure of abdominal adiposity, with type 2 diabetes and CHD through the potential intermediates of blood lipids, blood pressure and glycemic phenotypes. A polygenic risk score for WHRadjBMI based on 48 single nucleotide polymorphisms was constructed. The association of this score, a measure of genetic predisposition to abdominal adiposity, with cardiometabolic traits, type 2 diabetes, and CHD was tested in a Mendelian randomization analysis that combined case-control and cross-sectional datasets. Estimates for cardiometabolic traits were based on a combined dataset including summary results from 4 genome-wide association studies conducted from 2007 to 2015, consisting of up to 322 154 participants, as well as individual level, cross sectional data from the UK Biobank collected from 2007–2011, consisting of 111 986 individuals. Estimates for type 2 diabetes and CHD were derived from summary statistics of 2 separate genome-wide association studies conducted from 2007–2015, and including 149 821 individuals and 184 305 individuals, respectively, combined with individual level data from the UK Biobank. Genetic predisposition to increased WHRadjBMI. Type 2 diabetes and CHD. In 111 986 individuals in UK Biobank, the mean age was 57 [standard deviation (SD) 8] years, 58 845 participants (52.5%) were women and the mean waist-to-hip ratio was 0.875. Analysis of summary-level genome-wide association study results and individual-level UK Biobank data demonstrated that a one SD increase in WHRadjBMI mediated by the polygenic risk score was associated with 27 mg/dl higher triglyceride levels, 4.1 mg/dl higher two-hour glucose levels, and 2.1 mm Hg higher systolic blood pressure (each P ≤ 0.001). A one SD genetic increase in WHRadjBMI was also associated with a higher risk of type 2 diabetes [OR 1.77 CI 1.57, 2.00; absolute risk increase per 1000 participant years (ARI) 6.0 CI 4.4, 7.8; number of participants with type 2 diabetes outcome, 40 530] and CHD (OR 1.46 CI 1.32, 1.62; ARI 1.8 CI 1.3, 2.4; number of participants with CHD outcome, 66 440). A genetic predisposition to higher waist-to-hip ratio adjusted for body mass index was associated with increased risk of type 2 diabetes and coronary heart disease. These results provide evidence supportive of a causal association between abdominal adiposity and these outcomes.